Streetbeat News

Analyst Ratings

CAT

Goldman Sachs analyst Jerry Revich maintains a Buy rating on Caterpillar (NYSE:CAT) and raises the price target from $274 to $357, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:29 pm

SYM

Cantor Fitzgerald analyst Derek Soderberg has reiterated an Overweight rating on Symbotic (NASDAQ:SYM) and maintained a $60 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:27 pm

VTLE

Truist Securities analyst Neal Dingmann maintains a Buy rating on Vital Energy (VTLE) and raises the price target from $81 to $86 as of 5th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:22 pm

PLTR

Wedbush analyst Daniel Ives maintains an Outperform rating on Palantir Technologies (PLTR) and raises the price target from $25 to $30.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:20 pm

ON

Truist Securities analyst William Stein maintains a Buy rating on ON Semiconductor (NASDAQ:ON) but lowers the price target from $94 to $89 as of 5th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:19 pm

RANI

Wedbush analyst Andreas Argyrides has reiterated an Outperform rating on Rani Therapeutics Hldgs (NASDAQ:RANI) and maintained a price target of $8. This reaffirms Wedbush's positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:18 pm

MCD

Truist Securities analyst Jake Bartlett maintains a Buy rating on McDonald's (MCD) but lowers the price target from $345 to $340 as of 5th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:17 pm

ABBV

Truist Securities analyst Robyn Karnauskas maintains a Buy rating on AbbVie (NYSE:ABBV) and raises the price target from $180 to $195 as reported on 5th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:15 pm

VRNS

Wedbush analyst Daniel Ives upgraded Varonis Systems (NASDAQ:VRNS) from Neutral to Outperform and increased the price target from $35 to $65.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:13 pm

BGNE

JP Morgan analyst Jessica Fye has initiated coverage on BeiGene (NASDAQ:BGNE) with an Overweight rating and set a price target of $185.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 1:58 pm